This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
K Alex , E Pehek (2007). Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacology & Therapeutics 113, 296–320.
B Bar-Oz , T Einarson , A Einarson , R Boskovic , (2007). Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clinical Therapeutics 29, 918–926.
B Birmaher , DA Brent , RS Benson (1998). Summary of the practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry 37, 1234–1238.
JA Bridge , S Iyengar , BC Salary , RP Barbe , (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment – a meta-analysis of randomized controlled trials. Journal of the American Medical Association 297, 1683–1696.
N Brunello , P Blier , LL Judd , J Medlewicz , (2003). Noradrenaline in mood and anxiety disorders: basic and clinical studies. International Clinical Psychopharmacology 18, 191–202.
DB Bylund , AL Reed (2007). Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs? Neurochemistry International 51, 246–253.
JN Carlson , KE Visker , DM Mielsen , RW Keller , (1996). Chronic antidepressant drug treatment reducing turning behavior and increases dopamine levels in the medial prefrontal cortex. Brain Research 707, 122–126.
NJ Carrey , S Dursun , R Clements , K Renton , (2002). Noradrenergic and serotonergic neuroendocrine responses in prepubertal, peripubertal, and postpubertal rats pretreated with desipramine and sertraline. Journal of the American Academy of Child and Adolescent Psychiatry 41, 999–1006.
F Chen , AJ Lawrence (2003). The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study. Brain Research 976, 22–29.
KJ Clemens , JL Cornish , KM Li , GE Hunt , (2005). MDMA (‘Ecstasy’) and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Neuropharmacology 49, 195–207.
F Crews , J He , C Hodge (2007). Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacology, Biochemistry, and Behavior 86, 189–199.
JF Cryan , A Markou , I Lucki (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends in Pharmacological Sciences 23, 238–245.
TR de Jong , LJAE Snaphaan , T Pattij , JG Veening , (2006). Effects of chronic treatment of fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. European Neuropsychopharmacology 16, 39–48.
AJ Dean , BM McDermott , RT Marshall (2006). Psychotropic medication utilization in a child and adolescent mental health service. Journal of Child and Adolescent Psychopharmacology 16, 273–285.
MJ Detke , I Lucki (1995). Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behavioural Brain Research 73, 43–46.
CL DeVane (1999). Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cellular and Molecular Neurobiology 19, 443–466.
G Di Giovanni , V Di Matteo , M Pierucci , E Esposito (2008). Serotonin-dopamine interaction: electrophysiological evidence. Progress in Brain Research 172, 45–71.
V Di Matteo , G Di Giovanni , M Pierucci , E Esposito (2008). Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies. Progress in Brain Research 172, 7–44.
SC Dulawa , R Hen (2005). Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test. Neuroscience and Biobehavioral Reviews 29, 771–783.
BW Dunlop , CB Nemeroff (2007). The role of dopamine in the pathophysiology of depression. Archives of General Psychiatry 64, 327–337.
A Frazer (1997). Pharmacology of antidepressants. Journal of Clinical Psychopharmacology 17, 2S–18S.
M Gobbi , D Crespi , MC Foddi , C Fracasso , (1997). Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 356, 22–28.
WK Goodman , TK Murphy , EA Storch (2007). Risk of adverse behavioural effects with pediatric use of antidepressants. Psychopharmacology 191, 87–96.
CG Gurtman , KC Morley , KM Li , GE Hunt , (2002). Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. European Journal of Pharmacology 446, 89–96.
TA Hammad , T Laughren , J Racoosin (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 63, 332–339.
T Harada , K Sakamoto , J Ishigooka (2008). Incidence and predictors of activation syndrome induced by antidepressants. Depression and Anxiety 25, 1014–1019.
GA Hargreaves , IS McGregor (2007). Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcoholism: Clinical and Experimental Research 31, 1900–1907.
JG Hensler (2003). Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration. Life Sciences 72, 1665–1682.
K Hirano , T Seki , N Sakai , Y Kato , (2005). Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain. Brain Research 1053, 154–161.
G Hodes , L Yang , J Van Kooy , J Santollo , (2009). Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex. Neuroscience 163, 609–617.
PD Hrdina , TB Vu (1993). Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse 14, 324–331.
H Jick , JA Kaye , SS Jick (2004). Antidepressants and the risk of suicidal behaviours. Journal of the American Medical Association 292, 338–343.
K Kapornai , A Vetro (2008). Depression in children. Current Opinion in Psychiatry 21, 1–7.
MB Keller , ND Ryan , M Strober , RG Klein , (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomised, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 40, 762–772.
AMS Kindlundh-Hogberg , HB Schioth , P Svenningsson (2007). Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain. Neurotoxicology 28, 1158–1169.
S Koks , S Beljajev , I Koovit , U Abramov , (2001). 8-OH-DPAT, but not deramciclane, antagonises the anxiogenic-like action of paroxetine in an elevated plus-maze. Psychopharmacology 153, 365–372.
A Kugaya , NM Seneca , PJ Snyder , SA Williams , (2003). Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 28, 413–420.
KM Li , MR Thompson , IS McGregor (2004). Rapid quantification of fluoxetine and norfluoxetine in serum by micro-disc solid-phase extraction with high-performance liquid chromatography – ultraviolet absorbance detection. Journal of Chromatography, B: Biomedical Sciences and Applications 804, 319–326.
JL Luby (2009). Early childhood depression. American Journal of Psychiatry 166, 974–980.
O Malkesman , A Weller (2009). Two different putative genetic models of childhood depression – A review. Progress in Neurobiology 88, 153–169.
JJ Mann , DA Brent , V Argano (2001). The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 24, 467–477.
JJ Mann , GJ Emslie , RJ Baldessarini , W Beardslee , (2006). ACNP task force report on SSRIs and suicidal behaviour in youth. Neuropsychopharmacology 31, 473–492.
SS Mason , KB Baker , KW Davis , VM Pogorelov , (2009). Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains. European Journal of Pharmacology 602, 306–315.
CM McCormick , IZ Mathews , C Thomas , P Waters (2010). Investigations of HPA function and the enduring consequences of stressors in adolescence in animal models. Brain and Cognition 72, 73–85.
MJ Millan (2004). The role of monoamines in the actions of established and ‘novel’ antidepressant agents: a critical review. European Journal of Pharmacology 500, 371–384.
H Miura , T Kitagami , N Ozaki (2007). Suppressive effect of paroxetine, a selective serotonin reuptake inhibitor, on tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefronal cortex of mice. Synapse 61, 698–706.
LC Murrin , JD Sanders , DB Bylund (2007). Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochemical Pharmacology 73, 1225–1236.
ME Newman , G Shalom , A Ran , E Gur , (2004). Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635. European Journal of Pharmacology 486, 25–30.
J-E Oh , B Zupan , S Gross , M Toth (2009). Paradoxical anxiogenic response of juvenile mice to fluoxetine. Neuropsychopharmacology 34, 2197–2207.
M Olfson , SC Marcus , D Shaffer (2006). Antidepressant drug therapy and suicide in severely depressed children and adults. Archives of General Psychiatry 63, 865–872.
MJ Owens , DL Knight , CB Nemeroff (2000). Paroxetine binding to the rat norepinephrine transporter in vivo. Biological Psychiatry 47, 842–845.
T Paus (2005). Mapping brain maturation and cognitive development through adolescence. Trends in Cognitive Sciences 9, 61–68.
SM Pellis , VC Pellis (1997). The prejuvenile onset of play fighting in laboratory rats (Rattus norvegicus). Developmental Psychobiology 31, 193–205.
S Prisco , E Esposito (1995). Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. British Journal of Pharmacology 116, 1923–1931.
E Richelson (1996). Synaptic effects of antodepressants. Journal of Clinical Psychopharmacology 16, 1S–9S.
HT Robertson , DB Allison (2009). Drugs associated with more suicidal ideations are also associated with more suicide attempts. PLoS One 4, e7312.
E Ryding , M Lindstrom , L Traskman-Bendz (2008). The role of dopamine and serotonin in suicidal behaviour and aggression. Progress in Brain Research 172, 307–315.
Y Sekine , K Sukuzi , PV Ramachandran , TP Blackburn , (2007). Acute and repeated administration of fluoxetine, citalopram and paroxetine significantly alters the activity of midrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 61, 72–77.
I Sillaber , M Panhuysen , MSH Henniger , F Ohl , (2008). Profiling of behavioural changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology 200, 557–572.
LP Spear (2000). The adolescent brain and age-related behavioural manifestations. Neuroscience and Biobehavioural Reviews 24, 417–463.
LP Spear (2007). Assessment of adolescent neurotoxicity: rationale and methodological considerations. Neurotoxicology and teratology 29, 1–9.
M Stone , T Laughren , ML Jones , M Levenson , (2009). Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. British Medical Journal 339, b2880.
G Tanda , E Carboni , R Frau , G Di Chiara (1994). Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology 115, 285–288.
MR Thompson , KM Li , KJ Clemens , CG Gurtman , (2004). Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA (‘ecstasy’) in rats. Neuropsychopharmacology 29, 694–704.
DH Thor , WRJ Holloway (1984). Social play in juvenile rats: a decade of methodological and experimental research. Neuroscience and Biobehavioral Reviews 8, 455–464.
K Titier , N Castaing , E Scotto-Gomez , F Pehourcq , (2003). High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose. Therapeutic Drug Monitoring 25, 581–587.
EM Tsapakis , F Soldani , L Tondo , RJ Baldessarini (2008). Efficacy of antidepressants in juvenile depression: meta-analysis. British Journal of Psychiatry 193, 10–17.
V Wegerer , GH Moll , M Bagli , A Rothenberger , (1999). Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. Journal of Child and Adolescent Psychopharmacology 9, 13–24.
MM Weissman , S Wolk , RB Goldstein , D Moreau , (1999). Depressed adolescents grown up. Journal of the American Medical Association 281, 1707–1713.
CJ Whittington , T Kendall , P Fonagy , D Cottrell , (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published vs. unpublished data. Lancet 363, 1341–1345.
G Yadid , A Friedman (2008). Dynamics of the dopaminergic system as a key component to the understanding of depression. Progress in Brain Research 172, 265–286.
M Yamauchi , T Miyara , T Matsushima , T Imanishi (2006). Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors. Brain Research 1067, 164–169.